Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II, Single-Center, Randomized, Double-Blind Assessment of the Abuse Liability of Acurox (Oxycodone HCl and Niacin) Tablets in Subjects With a History of Opioid Abuse

NCT00699010 is registered in ClinicalTrials.gov with Acura Pharmaceuticals Inc. as lead sponsor.

NCT NCT00699010
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00699010 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II, Single-Center, Randomized, Double-Blind Assessment of the Abuse Liability of Acurox (Oxycodone HCl and Niacin) Tablets in Subjects With a History of Opioid Abuse
Lead sponsor
Acura Pharmaceuticals Inc.
Phase
Phase 2
Overall status
Completed
Start date
March 31, 2008
Completion date
August 31, 2008
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

opioid abuse